Access cutting-edge iga nephropathy treatment through this clinical trial at a research site in Montgomery. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Montgomery location
Access iga nephropathy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related iga nephropathy treatment provided free
Check if you qualify for this iga nephropathy clinical trial in Montgomery, AL
No-Cost Study Care
Local to Montgomery
Convenient for AL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Immunoglobulin A nephropathy (IgAN) is a kidney condition. It happens when the body's immune system creates groups of proteins (called immune complexes) that build-up in the kidneys causing swelling (inflammation). Over time, this inflammation may lead to kidney damage and cause the kidneys to no longer work properly. The main aim of this study is to check how well mezagitamab changes protein levels in the urine (proteinuria) compared to placebo in adults with primary IgAN. A placebo looks like
Sponsor: Takeda
Yes, this clinical trial (NCT06963827) has an active research site in Montgomery, AL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for iga nephropathy treatment options in Montgomery, AL, this clinical trial (NCT06963827) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Montgomery research site is actively enrolling participants for this clinical trial. You'll receive care from experienced iga nephropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all iga nephropathy clinical trials near you to find additional studies recruiting in your area.
See all iga nephropathy clinical trials recruiting in Montgomery — not just this study.
Browse IgA Nephropathy Trials in Montgomery →